DENTSPLY SIRONA Inc.·4

Jun 5, 5:40 PM ET

LUCIER GREGORY T 4

Research Summary

AI-generated summary

Updated

DENTSPLY SIRONA (XRAY) Director Gregory T. Lucier Receives RSUs and Gifts

What Happened
Gregory T. Lucier, a director of DENTSPLY SIRONA (XRAY), received a grant of 38,382 restricted stock units (RSUs) and a grant of 10,900 derivative awards (non-qualified stock options, NQSOs) on 2026-06-03 (reported on Form 4 filed 2026-06-05). Both grants are reported at $0.00 immediate cash value. Shortly after the grants, Lucier reported gifting those same RSUs and NQSOs to a family partnership. No cash proceeds were involved — these were an equity award and a contemporaneous gift/transfer.

Key Details

  • Transaction date(s): 2026-06-03; Form 4 filed 2026-06-05 (timely filing).
  • Grants: 38,382 RSUs (code A) and 10,900 NQSO-equivalent awards (code A, listed as derivative) at $0.00.
  • Gifts/transfers: Same amounts (38,382 RSUs and 10,900 NQSOs) were reported as gifted (code G) to a family partnership immediately after the grants.
  • Vesting/terms: RSUs vest in full one year from grant date (F1). Stock options vest in full one year from grant date (F3).
  • Ownership and control notes: Footnotes state the RSUs/NQSOs were gifted to a family partnership that includes a trust for Lucier’s benefit; his spouse is the partnership’s general partner and may have voting/dispositive power (F2, F4). Lucier disclaims beneficial ownership except to the extent of any pecuniary interest.
  • Transaction value: Reported at $0.00 (no cash exchanged at time of grant/transfer).
  • Filing timeliness: Form 4 was filed within the standard two-business-day window.

Context

  • Gifts to a family partnership are often estate/ownership-structure moves and do not necessarily signal a trading view on the company; they are disposals for reporting purposes but not open-market sales.
  • The derivative entries reflect unexercised NQSOs (not an exercise/cashless transaction); these options and the RSUs vest in one year per the filing.